Newron Pharmaceuticals S.p.A.

BRIEF

published on 04/08/2024 at 07:05, 1 year 10 months ago

Newron Pharmaceuticals partage des données prometteuses lors du congrès SIRS 2024

Essais Cliniques Schizophrénie Produits Pharmaceutiques Newron Evenamide Résistant Aux Traitements
BRIEF

published on 04/08/2024 at 07:05, 1 year 10 months ago

Newron Pharmaceuticals Shares Promising Data at 2024 SIRS Congress

Clinical Trials Schizophrenia Newron Pharmaceuticals Evenamide Treatment-resistant
PRESS RELEASE

published on 04/08/2024 at 07:00, 1 year 10 months ago

Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)
Newron Pharmaceuticals presented data from study 014/015 and evenamide clinical development outlook at SIRS 2024 Congress, showcasing potential for new TRS treatment options

Clinical Development Newron Pharmaceuticals Evenamide Study 014/015 Schizophrenia International Research Society
BRIEF

published on 03/19/2024 at 07:05, 1 year 10 months ago

Newron Pharmaceuticals SpA annonce ses résultats financiers pour 2023 et fournit des perspectives pour 2024

Perspectives 2024 Résultats Financiers 2023 Produits Pharmaceutiques Newron Xadago Safinamide Développement D'Evenamide
BRIEF

published on 03/19/2024 at 07:05, 1 year 10 months ago

Newron Pharmaceuticals S.p.A. Announces 2023 Financial Results and Provides Outlook for 2024

2024 Outlook Financial Results 2023 Newron Pharmaceuticals Evenamide Development Xadago Safinamide
PRESS RELEASE

published on 03/19/2024 at 07:00, 1 year 10 months ago

Newron presents 2023 financial results and provides 2024 outlook
Newron Pharmaceuticals S.p.A. presents 2023 financial results and 2024 outlook, including advancements in schizophrenia treatment and strategic partnerships

Financial Results 2024 Outlook Partnerships Newron Pharmaceuticals Schizophrenia Treatment
BRIEF

published on 03/15/2024 at 07:05, 1 year 10 months ago

Newron Pharmaceuticals SpA annonce un accord de remboursement modifié avec la Banque européenne d'investissement

Produits Pharmaceutiques Newron Evenamide Banque Européenne D'investissement Accord De Financement Traitements Du SNC
BRIEF

published on 03/15/2024 at 07:05, 1 year 10 months ago

Newron Pharmaceuticals S.p.A. Announces Amended Repayment Agreement with European Investment Bank

European Investment Bank Newron Pharmaceuticals Financing Agreement Evenamide CNS Treatments
PRESS RELEASE

published on 03/15/2024 at 07:00, 1 year 10 months ago

Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 financing agreement
Newron Pharmaceuticals S.p.A. agrees with EIB to extend repayment dates of 2018 financing agreement tranches after pipeline milestones

European Investment Bank Financing Agreement Evenamide Newron Pharmaceuticals S.p.A. Loan Repayment Dates
BRIEF

published on 03/14/2024 at 18:37, 1 year 10 months ago

Newron Pharmaceuticals obtient jusqu'à 15 millions d'euros de financement grâce à l'émission de nouvelles actions

Émission D'actions Produits Biopharmaceutiques Accord D'investissement Produits Pharmaceutiques Newron Thérapies Du SNC

Published on 02/09/2026 at 15:00, 2 hours 10 minutes ago

Gungnir Resources Inc. Announces Management And Board Changes
Published on 02/09/2026 at 14:15, 2 hours 55 minutes ago

White Gold Corp. Appoints Seasoned Mining Executive Donovan Pollitt as Strategic Advisor
Published on 02/09/2026 at 14:00, 3 hours 10 minutes ago

Paymetrex Secures First U.S. License Payment
Published on 02/09/2026 at 14:00, 3 hours 10 minutes ago

Geophysics Converge Ahead of Colosseum Deeper Drill Program
Published on 02/09/2026 at 13:00, 4 hours 10 minutes ago

Eagle Plains' Partner Refined Energy Corp. Mobilizes Geophysical Team to the Dufferin West Project, Saskatchewan

View all ACCESSWIRE

Published on 02/09/2026 at 16:49, 21 minutes ago

RM plc: Holding(s) in Company
Published on 02/09/2026 at 15:58, 1 hour 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Just Group plc
Published on 02/09/2026 at 15:47, 1 hour 23 minutes ago

Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 02/09/2026 at 15:45, 1 hour 25 minutes ago

Form 8.3 - The Vanguard Group, Inc.: NCC Group plc
Published on 02/09/2026 at 15:43, 1 hour 27 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited

View all EQS

Published on 02/09/2026 at 14:49, 2 hours 21 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/09/2026 at 10:40, 6 hours 30 minutes ago

Déclaration mensuelle du nombre total de droits de vote et du nombre d’actions composant le capital
Published on 02/09/2026 at 08:30, 8 hours 40 minutes ago

THERMADOR GROUPE : Plan to separate the roles of chairman and chief executive officer
Published on 02/09/2026 at 08:30, 8 hours 40 minutes ago

THERMADOR GROUPE : Projet de séparation des mandats de président et directeur général
Published on 02/09/2026 at 08:00, 9 hours 10 minutes ago

Eiffage renforce son expertise dans le secteur du froid industriel avec une prise de participation majoritaire dans l’entreprise française Quercy Réfrigération

View all LES ECHOS COMFI WIRE

News